Biblio

Author [ Title(Desc)] Type Year
Filters: Author is Chen, Yao  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
8
Xu, L.Ping, Chen, Y., Shi, H.Xia, and Huang, X.Jun (2013). [8p11 myeloproliferative syndrome cured by allogeneic hematopoietic stem cell transplantation: two case reports and literature review].Beijing Da Xue Xue Bao45, 993-6.
A
Tang, F.-F., Huang, X.-J., Zhang, X.-H., Chen, H., Chen, Y.-H., Han, W., Chen, Y., Wang, F.-R., Wang, Y., Wang, J.-Z., et al. (2016). Allogeneic hematopoietic cell transplantation for adult patients with treatment-related acute myeloid leukemia during first remission: Comparable to de novo acute myeloid leukemia.Leuk Res47, 8-15.
Xu, L.-P., Xu, Z.-L., Zhang, X.-H., Chen, H., Chen, Y.-H., Han, W., Chen, Y., Wang, F.-R., Wang, J.-Z., Wang, Y., et al. (2016). Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid Leukemia.Biol Blood Marrow Transplant.
C
Du, M., Schmull, S., Zhang, W., Wang, C., Lian, F., Chen, Y., and Xue, S. (2016). c-kit(+)AT2R(+) Bone Marrow Mononuclear Cell Subset Is a Superior Subset for Cardiac Protection after Myocardial Infarction.Stem Cells Int2016, 4913515.
Ma, R., Huang, X.-J., Xu, L.-P., Liu, K.-Y., Zhang, X.-H., Yan, C.-H., Han, W., Wang, F.-R., Chen, Y.-H., Chen, H., et al. (2019). Comparable Outcomes after Hematopoietic Stem Cell Transplantation from Mother Donors and Matched Unrelated Donors in Patients with Hematopoietic Malignancies.Biol Blood Marrow Transplant.
Chen, Y., Fu, W.-J., Xu, L.-P., Ren, H.-Y., Lai, Y.-R., Liu, D.-H., Liu, L., Sun, Z.-M., Bin Wu, Y.-, Wang, X., et al. (2019). Comparison of outcomes after human leukocyte antigen-matched and haploidentical hematopoietic stem-cell transplantation for multiple myeloma.Chin Med J (Engl).
F
Chen, Y., Huang, X.-J., Wang, Y., Liu, K.-Y., Chen, H., Chen, Y.-H., Zhang, X.-H., Wang, F.-R., Han, W., Wang, J.-Z., et al. (2015). Febrile reaction associated with the infusion of haploidentical peripheral blood stem cells: incidence, clinical features, and risk factors.Transfusion.
H
Zhang, X.-H., Feng, F.-E., Han, W., Wang, F.-R., Wang, J.-Z., Wang, Y., Chen, Y., Fu, H.-X., Mo, X.-D., Zhang, Y.-Y., et al. (2016). High-dose corticosteroid associated with catheter-related thrombosis after allogeneic hematopoietic stem cell transplantation.Thromb Res144, 6-11.
I
Yan, C.-H., Wang, Y., Mo, X.-D., Sun, Y.-Q., Wang, F.-R., Fu, H.-X., Chen, Y., Han, T.-T., Kong, J., Cheng, Y.-F., et al. (2018). Incidence, Risk Factors, Microbiology and Outcomes of Pre-engraftment Bloodstream Infection After Haploidentical Hematopoietic Stem Cell Transplantation and Comparison With HLA-identical Sibling Transplantation.Clin Infect Dis67, S162-S173.
P
Liu, M.-M., Guo, Z.-Z., Liu, H., Li, S.-H., Chen, Y., Zhong, Y., Lei, Y., Lin, X.-H., and Liu, A.-L. (2019). Paper-based 3D culture device integrated with electrochemical sensor for the on-line cell viability evaluation of amyloid-beta peptide induced damage in PC12 cells.Biosens Bioelectron144, 111686.
R
Zhang, X.-H., Wang, G.-X., Zhu, H.-H., Liu, Y.-R., Xu, L.-P., Han, W., Chen, H., Chen, Y.-H., Wang, F.-R., Wang, J.-Z., et al. (2015). Recruitment of CD8(+) T cells into bone marrow might explain the suppression of megakaryocyte apoptosis through high expression of CX3CR1(+) in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation.Ann Hematol.
Chen, Y., Xu, L.-P., Liu, K.-Y., Chen, H., Chen, Y.-H., Zhang, X.-H., Wang, Y., Wang, F.-R., Han, W., Wang, J.-Z., et al. (2015). Risk factors for cytomegalovirus DNAemia following haploidentical stem cell transplantation and its association with host hepatitis B virus serostatus.J Clin Virol75, 10-15.